Table 1.
Baseline characteristics
Stoma closure n = 104 |
No stoma closure n = 51 |
|
---|---|---|
Male | 53 (51.0%) | 29 (56.9%) |
Female | 51 (49.0%) | 22 (43.1%) |
Age (years) | ||
−50 | 3 (2.9%) | 5 (9.8%) |
50–60 | 22 (21.2%) | 6 (11.8%) |
60–70 | 35 (33.7%) | 16 (31.4%) |
70–80 | 34 (32.7%) | 13 (25.5%) |
80+ | 10 (9.6%) | 11 (21.6%) |
BMI (kg/m2) | 25 (17–38) | 24 (18–40) |
BMI ≤ 30 | 80 (85.1%) | 39 (83.0%) |
BMI > 30 | 14 (14.9%) | 8 (17.0%) |
ASA-classification | ||
ASA 1–2 | 81 (77.9%) | 33 (64.7%) |
ASA 3–5 | 23 (22.1%) | 18 (35.3%) |
Duration of symptoms prior to presentation (days) | 6 (0–173) | 5 (0–154) |
Preoperative hemoglobin (mmol/L) | 8.8 (4.7–11.7) | 8.5 (5.2–11.4) |
Preoperative leukocyte count (× 109/L) | 11.4 (4.1–27.2) | 11.1 (4.7–24.0) |
Preoperative C-reactive protein (mg/L) | 10 (1–239) | 22 (1–290) |
Preoperative eGFR (mL/min/1.73 m2) | 83 (32–154) | 76 (12–130) |
Clinical M-stage | ||
cM0 | 92 (91.1%) | 32 (64.0%) |
cM1 | 9 (8.9%) | 18 (36.0%) |
Type of resection | ||
Sigmoidectomy | 61 (58.7%) | 26 (51.0%) |
Left hemicolectomy | 20 (19.2%) | 11 (21.6%) |
Subtotal colectomy | 2 (1.9%) | 3 (5.9%) |
Low anterior resection (partial mesorectal excision) | 18 (17.3%) | 6 (11.8%) |
Sigmoidectomy + right hemicolectomy | 3 (2.9%) | 4 (7.8%) |
Transverse colon resection | 0 (0.0%) | 1 (2.0%) |
Approach of operation | ||
Open | 92 (88.5%) | 51 (100.0%) |
Laparoscopic | 12 (11.5%) | 0 (0.0%) |
Stoma location | ||
Ileum | 80 (76.9%) | 37 (72.5%) |
Ascending colon | 1 (1.0%) | 3 (5.9%) |
Transverse colon | 21 (20.2%) | 7 (13.7%) |
Descending colon | 2 (1.9%) | 4 (7.8%) |
Pathological tumor stage | ||
pT2 | 3 (2.9%) | 0 (0.0%) |
pT3 | 74 (71.2%) | 34 (66.7%) |
pT4 | 27 (26.0%) | 17 (33.3%) |
pN0 | 48 (46.2%) | 17 (33.3%) |
pN1 | 34 (32.7%) | 19 (37.3%) |
pN2 | 22 (21.2%) | 15 (29.4%) |
Data are given as number of cases (%). Continuous variables were given as median (range)
BMI, body mass index; ASA, American Society of Anesthesiologists; eGFR, estimated glomerular filtration rate